Breast Cancer
-
Pink Ribbons and Pink Profits: What Really Drives Breast Cancer Campaign Support
MANILA, July 2 — A new study is shedding light on what truly drives people to support breast cancer campaigns, and the…
-
Anixa Biosciences Gets First Korean Patent for Breast Cancer Vaccine
SAN JOSE, June 29 — Anixa Biosciences has secured its first Korean patent for a breast cancer vaccine, a move that extends…
-
South Korea Grants Anixa Biosciences Strong Patent for Breast Cancer Vaccine
South Korea just gave a California biotech firm a patent that runs until 2040. That matters for women in Central Asia. The…
-
Genes controlling cell adhesion linked to breast cancer spread risk
Breast cancer doesn’t kill by sitting still. It kills when cells break loose, travel, and start new tumors elsewhere. A study published…
-
Anixa Biosciences Secures First Korean Patent for Breast Cancer Vaccine
Anixa’s Korean Patent Opens Door to Clinical Trials in Asia SAN JOSE — The patent paperwork is done. Now comes the hard…
-
Study: Cell junction genes vary by breast cancer subtype in Asian patients
TOKYO — Breast cancer rates are climbing across Asia. That much is known. What is less understood is how to match each…
-
Scientists Find the Switch That Exhausts CAR T Cells in Cancer
NEW YORK, June 7, 2026 — cyberinktimes.com — Researchers have identified a master switch that exhausts CAR T cells and shown how…
-
Columbia Researchers Discover Switch That Reverses Cancer-Fighting Cell Burnout
Engineered immune cells known as CAR‑T cells have revolutionized treatment for blood cancers, yet their impact on solid tumors such as breast,…
-
FDA Approves Genentech’s Dual-Action Breast Cancer Drug Inavolisib
On 15 October 2024, the U.S. Food and Drug Administration granted market authorization to Inavolisib, a novel therapy from Genentech, a Roche…
-
Talzenna Offers Hope Despite Significant Side Effects for Cancer Patients
Patients taking talazoparib, marketed as Talzenna, routinely report a range of adverse reactions that include fatigue, anemia, nausea, neutropenia, headache, thrombocytopenia, vomiting,…
Most read
-
Minnesota Makes Personal Finance Course Mandatory for High School Graduation
-
UK Households With £10,000 Risk Losing £300 To Low Interest Rates
-
Selangor International Care Expo in Kuala Lumpur 2026
-
Asian & Oceanian Epilepsy Congress 2026 in Kuala Lumpur
-
Baby & Beyond Maternity Expo in Kuala Lumpur 2026
-
Why Long COVID Raises Hypertension Risk and How to Monitor Your Blood Pressure
-
Amgen and AstraZeneca Combination Therapy Shows Unprecedented Survival Gains in Lung Cancer
-
Moderna’s mRNA Platform Enables Rapid Personalized Cancer Vaccines
-
Evaluating Skyrizi’s Efficacy and Market Position in Crohn’s Disease Care
-
How Personalized mRNA Vaccines Target Neoantigens to Beat Melanoma
-
Nationwide Rate Boost: How Rising Cash ISA Yields Beat Inflation Without Long-Term Lock-Ins
-
Estate Taxes Hit Retirees Selling High-Value Art: Navigating Double Taxation Risks
-
How Revolving Credit Card Balances Drive Industry Profits and Stifle Budgets
-
Why Medicare Documentation Rules Drive Denied Claims for Diabetic Shoes
-
Suze Orman: Why Medical Costs Demand an 8-Month Emergency Fund
-
BMS GPRC5D CAR-T Arlo-cel Shows Deep Responses After BCMA Failure
-
Understanding the FDA’s Accelerated Approval of Iberdomide for Multiple Myeloma
-
Rockefeller’s 2141-V11 Trial Shows Complete Remission in Two Metastatic Cancer Patients
-
Personalized mRNA Cancer Vaccine Succeeds in First Phase 3 Melanoma Trial
-
Dennis Lo Pioneers Liquid Biopsy for Cancer and Prenatal Testing
-
New Research Highlights Rising Internet Addiction Debate
-
Study Suggests Drinking Water With Meals May Lead To Overeating
-
Real-World Oncotype DX Adoption: Rates and Key Challenges
-
Energy Drinks: Youth Marketing, Caffeine Risks Under Scrutiny
-
ADHD Dopamine Dysfunction Disrupts Sleep-Wake Cycles, Study Finds